WASHINGTON, DC – House Energy and Commerce Committee leaders are seeking further information regarding the costs and benefits of EPA’s proposed stringent new standards for fine particulate matter (PM 2.5).
Committee Leaders Ask EPA to Update its Cost-Benefit Analysis of Proposed Particulate Matter StandardsNovember 16, 2012 | Press Release
WASHINGTON, DC – Communications and Technology Subcommittee Chairman Greg Walden (R-OR) today announced all five FCC commissioners will testify on “Keeping the New Broadband Spectrum Law on Track” on Wednesday, December 12, 2012. Details will be posted here as they become available.
Committee Poses Questions to HHS Regarding Potential Conflict of Interest Concerns Surrounding Health ExchangesNovember 13, 2012 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) and Oversight and Investigations Subcommittee Chairman Cliff Stearns (R-FL) today requested the Department of Health and Human Services provide information on the contract awarded to Quality Software Services, Inc. (QSSI) to support health exchanges. The QSSI contract has not been made publicly available, and the company’s recent acquisition by United Health Group has raised concerns about its role.
WASHINGTON, DC – Energy and Power Subcommittee Chairman Ed Whitfield (R-KY) released the following statement in response to the Bureau of Land Management’s proposed plan for oil shale and oil sands leasing on Western lands. BLM published its proposal today, which will block off an additional 1.6 million acres of federal lands from leasing.
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) and Communications and Technology Subcommittee Greg Walden (R-OR) today issued the following statements after AT&T announced plans to invest $14 billion to expand its broadband network:
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI), after consultation with Ranking Member Henry A. Waxman (D-CA), today issued a subpoena for Barry Cadden, New England Compounding Center Co-owner and Managing Pharmacist, to appear before the Oversight and Investigations Subcommittee on November 14, 2012, to testify about the deadly meningitis outbreak. Through his counsel, Cadden has declined to appear voluntarily.